Find, compare & contact
Latanoprost API Manufacturers & Suppliers

Looking for Latanoprost API 130209-82-4?

Description:

Here you will find a list of producers, manufacturers and distributors of Latanoprost. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Latanoprost 

Synonyms:

Latanoprost , Latanoprostum , PhXA 41 , Xalatan  

Cas Number:

130209-82-4 

DrugBank number:

DB00654 

Unique Ingredient Identifier:

6Z5B6HVF6O

Latanoprost is a type of Ocular preparations

Ocular preparations are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used in the formulation of medications and treatments for various eye conditions. These specialized formulations are designed to deliver therapeutic agents directly to the eye, ensuring maximum effectiveness and minimal systemic absorption.

Ocular preparations encompass a wide range of products, including eye drops, ointments, gels, and inserts. These formulations may contain API components such as antibiotics, corticosteroids, antihistamines, lubricants, or mydriatics, depending on the intended therapeutic purpose.

Eye drops are the most common form of ocular preparations, delivering medications in liquid form directly onto the eye surface. They are often used to treat conditions like dry eyes, glaucoma, allergies, and infections. Ointments and gels provide a more viscous consistency, enabling longer contact time with the eye surface and prolonged drug release. Inserts, such as punctal plugs, are used to deliver sustained-release medications.

Ocular preparations are formulated to ensure compatibility with the delicate structures of the eye and to enhance drug penetration. Factors like pH, osmolality, and viscosity are carefully controlled to optimize drug delivery and patient comfort. Additionally, preservatives are often added to prevent microbial contamination and maintain product stability.

In summary, ocular preparations are crucial in treating various eye conditions effectively. They provide targeted drug delivery and ensure optimal therapeutic outcomes with minimal side effects. Whether in the form of eye drops, ointments, gels, or inserts, these pharmaceutical APIs play a vital role in promoting eye health and improving patient well-being.

Latanoprost (Ocular preparations), classified under Ophthalmic Agents

Ophthalmic agents belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category specifically designed for ophthalmic applications. These agents are formulated to treat various eye conditions and disorders. Ophthalmic agents encompass a wide range of medications, including eye drops, ointments, gels, and intraocular implants.

These agents are developed to address specific therapeutic needs related to the eyes, such as reducing intraocular pressure in glaucoma, treating inflammation and infection, relieving dryness and itching, and managing allergies. They may also be used to dilate the pupils during diagnostic procedures or surgeries.

Ophthalmic agents are formulated with precise concentrations of active ingredients to ensure efficacy and safety. Common classes of ophthalmic agents include beta-blockers, prostaglandin analogs, carbonic anhydrase inhibitors, corticosteroids, and antihistamines.

When administering ophthalmic agents, it is crucial to follow proper application techniques to ensure optimal drug delivery and minimize side effects. Eye drops, for example, are typically applied as a gentle instillation into the conjunctival sac, while ointments are applied along the lower eyelid.

These pharmaceutical API ophthalmic agents undergo rigorous quality control and regulatory scrutiny to meet industry standards and ensure patient safety. Manufacturers must comply with Good Manufacturing Practices (GMP) and adhere to stringent quality assurance protocols.

Overall, ophthalmic agents play a vital role in the management and treatment of various eye conditions, providing patients with targeted relief and improving ocular health. It is important to consult with a healthcare professional to determine the appropriate ophthalmic agent for individual needs and to receive proper guidance on usage and potential side effects.

• Chirogate International from Taiwan, product country of origin Taiwan
• LGM Pharma from United States, product country of origin World
• AXXO GmbH from Germany, product country of origin European Union
• Changzhou Comwin Fine Chemicals Co., Ltd from China, product country of origin China
• Kyowa Pharma Chem. from Japan, product country of origin Unknown
• Chinoin from Hungary, product country of origin Unknown
• Yonsung Fine Chem. from South Korea, product country of origin South Korea
• Teva API from Israel, product country of origin Unknown
• Quimdis from France, product country of origin Unknown
• Patheon from Austria, product country of origin Austria
• Finetech Pharma from Israel, product country of origin Israel
• Flavine from Germany, product country of origin Unknown
• Jiangxi Bioman Pharma Limited from China, product country of origin China
• Biocon from India, product country of origin India
• Shanghai Tianwei Biology Pharmacy from China, product country of origin China
• TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
• Laurus Labs from India, product country of origin India
• Industriale Chimica from Italy, product country of origin Unknown
• Mylan from India, product country of origin India
• MSN Labs. from India, product country of origin India
• Lupin from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.